KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q3 2025 value amounting to -$35.3 million.

  • Vertex Pharmaceuticals' Change in Account Payables fell 15340.39% to -$35.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year decrease of 2580.65%. This contributed to the annual value of $49.5 million for FY2024, which is 164.27% up from last year.
  • Latest data reveals that Vertex Pharmaceuticals reported Change in Account Payables of -$35.3 million as of Q3 2025, which was down 15340.39% from $7.6 million recorded in Q2 2025.
  • Vertex Pharmaceuticals' 5-year Change in Account Payables high stood at $159.9 million for Q4 2022, and its period low was -$69.9 million during Q3 2022.
  • For the 5-year period, Vertex Pharmaceuticals' Change in Account Payables averaged around $13.1 million, with its median value being $7.6 million (2025).
  • Its Change in Account Payables has fluctuated over the past 5 years, first plummeted by 342524.27% in 2021, then soared by 2610000.0% in 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Change in Account Payables (Quarter) stood at $53.9 million in 2021, then soared by 196.66% to $159.9 million in 2022, then plummeted by 119.89% to -$31.8 million in 2023, then soared by 126.42% to $8.4 million in 2024, then crashed by 520.24% to -$35.3 million in 2025.
  • Its Change in Account Payables was -$35.3 million in Q3 2025, compared to $7.6 million in Q2 2025 and $26.2 million in Q1 2025.